In this episode, I interviewed Daniel Montoro, the CEO of TenSixty Biosciences. Dan and his team operate at the intersection of genomics, proteomics, machine learning, and cancer biology as they work to revolutionize cancer treatment. Dan has taken quite an unusual path, and generously shared his journey to becoming a CEO of a growing biotech company.
Show more...